[
  {
    "ts": "2025-10-18T00:16:52+00:00",
    "headline": "Boston Scientific (BSX): Assessing Valuation as Shares Post Steady Gains",
    "summary": "Boston Scientific (BSX) has seen its stock gradually climb in recent weeks, supported by consistent revenue and net income growth. Investors are likely watching the pace of these gains to gauge whether the company’s momentum can be sustained. See our latest analysis for Boston Scientific. After an impressive start to the year, Boston Scientific’s share price now sits at $99.24, posting an 11% return year-to-date. Recent momentum has been steady, supporting a solid 1-year total shareholder...",
    "url": "https://finance.yahoo.com/news/boston-scientific-bsx-assessing-valuation-001652543.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "e9f06924-ddf6-318d-ba45-66f6a52a6083",
      "content": {
        "id": "e9f06924-ddf6-318d-ba45-66f6a52a6083",
        "contentType": "STORY",
        "title": "Boston Scientific (BSX): Assessing Valuation as Shares Post Steady Gains",
        "description": "",
        "summary": "Boston Scientific (BSX) has seen its stock gradually climb in recent weeks, supported by consistent revenue and net income growth. Investors are likely watching the pace of these gains to gauge whether the company’s momentum can be sustained. See our latest analysis for Boston Scientific. After an impressive start to the year, Boston Scientific’s share price now sits at $99.24, posting an 11% return year-to-date. Recent momentum has been steady, supporting a solid 1-year total shareholder...",
        "pubDate": "2025-10-18T00:16:52Z",
        "displayTime": "2025-10-18T00:16:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-assessing-valuation-001652543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-assessing-valuation-001652543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]